Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Bioreliance Ltd. | Glasgow Lanarkshire, United Kingdom | Makes it and tests it | Problems found, fixed voluntarilyMay 13, 2026 · 7 inspections |
| CELLTRION Inc | Incheon, South Korea | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMay 3, 2024 · 8 inspections, 1 with FDA action |
| Patheon Italia S.p.A | Ferentino, Italy | Makes it and tests it | Problems found, fixed voluntarilyFeb 25, 2022 · 7 inspections, 1 with FDA action |
| Patheon Italia S.p.A. | Monza, Italy | Makes it and tests it | Problems found, fixed voluntarilyMay 26, 2023 · 10 inspections |
| Advanced Therapies, LLC | Philadelphia, PA, United States | Tests it | No problems foundFeb 7, 2025 · 5 inspections |
| Bioreliance Ltd. | Penicuik, United Kingdom | Tests it | No problems foundSep 7, 2016 · 2 inspections |
| Celltrion Pharm, Inc | Cheongju, South Korea | Packages it | Problems found, fixed voluntarilyJul 23, 2024 · 1 inspection |
| Samsung Biologics Co., Ltd. | Incheon, South Korea | Tests it | Problems found, fixed voluntarilySep 1, 2023 · 3 inspections |
| Sterigenics Belgium (Petit Rechain) SRL | Verviers, Belgium | Sterilizes it | Problems found, fixed voluntarilyJun 29, 2023 · 3 inspections |
| Sterigenics Germany GMBH | Wiesbaden, Germany | Tests it | Not inspected on record |
| Steripack Medical Poland SP Z O O | Leg, Poland | Tests it and packages it | Not inspected on record |
Product details
- Generic drug
- Aflibercept: every company that makes it
- Form
- injection
- Strength
- 2 mg per 0.05 mL
- Approval
- BLA BLA761377
- On the market since
- Sep 26, 2024
- Package NDCs
72606-026-0172606-026-02- Official label
- DailyMed (National Library of Medicine), updated Oct 17, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?